Your browser doesn't support javascript.
loading
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.
Gu, Shengqing Stan; Zhang, Wubing; Wang, Xiaoqing; Jiang, Peng; Traugh, Nicole; Li, Ziyi; Meyer, Clifford; Stewig, Blair; Xie, Yingtian; Bu, Xia; Manos, Michael P; Font-Tello, Alba; Gjini, Evisa; Lako, Ana; Lim, Klothilda; Conway, Jake; Tewari, Alok K; Zeng, Zexian; Sahu, Avinash Das; Tokheim, Collin; Weirather, Jason L; Fu, Jingxin; Zhang, Yi; Kroger, Benjamin; Liang, Jin Hua; Cejas, Paloma; Freeman, Gordon J; Rodig, Scott; Long, Henry W; Gewurz, Benjamin E; Hodi, F Stephen; Brown, Myles; Liu, X Shirley.
Afiliação
  • Gu SS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zhang W; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Wang X; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jiang P; School of Life Science and Technology, Tongji University, Shanghai, China.
  • Traugh N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Li Z; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Meyer C; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stewig B; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Xie Y; School of Life Science and Technology, Tongji University, Shanghai, China.
  • Bu X; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Manos MP; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Font-Tello A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gjini E; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lako A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lim K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Conway J; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tewari AK; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zeng Z; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sahu AD; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tokheim C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Weirather JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Zhang Y; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Kroger B; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liang JH; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Cejas P; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Freeman GJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Rodig S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Long HW; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gewurz BE; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hodi FS; School of Life Science and Technology, Tongji University, Shanghai, China.
  • Brown M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liu XS; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Cancer Discov ; 11(6): 1524-1541, 2021 06.
Article em En | MEDLINE | ID: mdl-33589424
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos